ArticleFrontiers in immunology2023

Plasma PD-L1 as a biomarker in the clinical management of glioblastoma multiforme-a retrospective cohort study.

Aetsam Bin Masood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.